Accelerating commercialization
from science

We are the interface bridging TRIUMF—Canada's national particle accelerator laboratory—with the business world.  We link cutting-edge science and technology to tangible business opportunities. 

"The Canadian Medical Isotope Ecosystem Development Fund has been created with the goal of identifying, funding and ultimately commercializing promising early-stage medical isotope technologies and radiopharmaceutical research from across the country. Our primary objective is to accelerate the development of great Canadian technology for the benefit of Canadian patients and the medical community." - Owen Roberts, CEO of the Centre for Probe Development and Commercialization, Co-Lead for the CMIE 

TRIUMF provides us with a unique ability to test our space borne systems, and present insights into how our electronics will behave in harsh radiation environment of space over several years. Our group has been coming to TRIUMF PIF for over two decades and on many occasions the results were quite surprising. Testing at TRIUMF allowed us to save time, money, and a significantly reduced risk of failure of our products for our customers. Last but not least, the TRIUMF team played a vital role in the success of our test campaigns. They did so by accommodating us in various ways to ensure we could complete our tests in a more efficient manner than originally scheduled." - Valeri Kirischian, Ph.D., P.Eng, FPGA/Embedded Systems Engineer,MDA Robotics and Automation